Monarch Partners Asset Management LLC Agios Pharmaceuticals, Inc. Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 58,246 shares of AGIO stock, worth $3.44 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
58,246
Previous 57,820
0.74%
Holding current value
$3.44 Million
Previous $1.64 Million
-0.0%
% of portfolio
0.5%
Previous 0.49%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$335 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$328 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$287 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$221 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$167 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $3.24B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...